Fresenius Medical Care appoints Joseph Turk as new Management Board Member for Care Enablement

Core Insights - Fresenius Medical Care has appointed Joseph E. Turk as the new Chief Executive Officer of the global operating segment Care Enablement, effective January 1, 2026, succeeding Dr. Katarzyna Mazur-Hofsäß who is retiring [1][2][7] Company Leadership Transition - The transition is part of a planned succession as Dr. Mazur-Hofsäß has informed the Supervisory Board of her intention to retire after leading Care Enablement since its inception in 2022 [2][4] - Joseph Turk has been with Fresenius Medical Care since 2019 and has held significant roles, including Executive Vice President of Global Home and Critical Care Therapies [3][4] Management Board Comments - Michael Sen, Chairman of the Supervisory Board, expressed confidence in Turk's ability to continue improving margins and advancing innovation within Care Enablement [4] - Helen Giza, CEO and Chair of the Management Board, highlighted Turk's strong track record and his role in executing the FME Reignite strategy [4] Company Overview - Fresenius Medical Care is the leading provider of products and services for individuals with renal diseases, serving approximately 4.2 million patients globally who undergo dialysis treatment [4] - The company operates a network of 3,676 dialysis clinics, providing treatments for around 300,000 patients worldwide [4]